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Available online 13 February 2013Abstract In vitro erythropoiesis has been studied extensively for its application in the manufacture of transfusable
erythrocytes. Unfortunately, culture conditions have not been as effective as in vivo growth conditions, where bone marrow
macrophages are known to be a key regulator of erythropoiesis. This study focused on the fact that some erythroblasts are
detached from macrophages and only contact other erythroblasts. We hypothesized that additional factors regulate
erythroblasts, likely through either physical contact or secreted factors. To further elucidate these critical factors, human
erythroblasts derived from cord blood were cultured at high density to mimic marrow conditions. This growth condition
resulted in a significantly increased erythroid enucleation rate and viability. We found several novel contact-related signals in
erythroblasts: intercellular adhesion molecule-4 (ICAM-4) and deleted in liver cancer-1 (DLC-1). DLC-1, a Rho-GTPase-activating
protein, has not previously been reported in erythroid cells, but its interaction with ICAM-4 was demonstrated here. We further
confirmed the presence of a secreted form of human ICAM-4 for the first time. When soluble ICAM-4 was added to media, cell
viability and enucleation increased with decreased nuclear dysplasia, suggesting that ICAM-4 is a key factor in contact between
cells. These results highlight potential new mechanisms for autonomous control of erythropoiesis. The application of these
procedures to erythrocyte manufacturing could enhance in vitro erythrocyte production for clinical use.
© 2013 Elsevier B.V. All rights reserved.Introduction
Definitive erythropoiesis occurs in the bone marrow, where a
set of complex interactions encourages red blood cell (RBC)
production. The central macrophage in the erythropoieticAbbreviations: Hb, hemoglobin; ICAM-4, intercellular adhesion
molecule-4; DLC-1, deleted in liver cancer-1.
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http://dx.doi.org/10.1016/j.scr.2013.02.003niches called erythroblastic islands plays a critical role in
controlling the maturation, differentiation, and enucleation
of erythroid cells (Bessis, 1958; Chasis and Mohandas, 2008).
It is known that the main route of signal transport between
macrophages and erythroid cells is physical contact via
several ligands and receptors (Rhodes et al., 2008; Soni et al.,
2006; Spring and Parsons, 2000; Telen, 2000). Various adhesion
molecules responsible for maintaining this cell-to-cell contact
within the erythroid islands have been identified, mainly
through the relationship between macrophages and erythroid
cells. However, not every erythroid cell is attached to a
macrophage (Rhodes et al., 2008), and some erythroid cells
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able to autonomously regulate erythropoiesis, albeit with
reduced efficiency (Chasis and Mohandas, 2008). Based on
these observations, we speculated that there must be factors
regulating erythroid cells that are not based on direct contact
with macrophages.
One potential explanation is autonomous regulation among
erythroid cells through direct contact, as they reside in
clusters within the bone marrow (Neu et al., 2003). However,
no secreted factors regulating erythropoiesis or signal trans-
duction between mature erythroid cells have been identified.
Fas-FasL is known to be involved in the apoptotic control of
pro-erythroblasts via mature polychromatic erythroblasts
(Allen and Dexter, 1982; Manwani and Bieker, 2008). However,
the role of this ligand and receptor has not been studied with
regard to the final maturation or enucleation of mature
erythroid cells. Erythroblast macrophage protein (Emp) is
known to be involved in macrophage–erythroblast attachment
and possibly in homotypic erythroblast attachment, but there
have been no data establishing this link (Soni et al., 2006).
Additionally, there have been no reports that erythropoiesis is
controlled via an auto-paracrine system (Manwani and Bieker,
2008).
Elucidation of the diverse systems regulating erythroid cells
is important not only for understanding basic and pathologic
erythropoiesis, but also for developing strategies for generating
human RBCs in vitro for transfusion. The severe blood supply
shortage and the ongoing need for safe blood have underscored
efforts to develop RBCs in vitro (Chasis, 2006; Sato et al.,
1979). However, the process of obtaining final RBC products
is still inefficient, mainly due to a low enucleation rate and
low viability in the final maturation step, particularly in
stromal-cell-free conditions. The enucleation process, where
immature erythroid cells extrude their nuclei, is a critical step
towards those cells becoming reticulocytes and finally mature
RBCs (Sato et al., 1979). Our knowledge regarding which
mechanisms regulate these final processes and why enucle-
ation and viability in vitro are so markedly low is lacking.
In order to elucidate the missing mechanisms of the
regulatory system of erythroid cells and to identify methods
to increase RBC production, we focused on the bone marrow
microenvironment, in which mature erythroid cells reside in
compact clusters. In conventional culture densities (less than
50% confluency) (Miharada et al., 2006), the erythroid cells
repel each other in suspension due to strong negative charges
on their surface membranes, and do not easily attach as other
adhesive cells do. To mimic bone marrow conditions, homog-
enous erythroid cells were cultured at a high density to increase
the chance of contact; the results revealed a significantly
increased enucleation rate and viability.
This prompted us to hypothesize that there are adhesion
factors that control terminal maturation and enucleation
among erythroid cells in the absence of macrophages. To
identify candidate genes affecting erythroid cell attachment
and enucleation, we searched for genes showing marked
changes before and after enucleation via microarray. By
comparing the candidate gene profiles of erythroid cells
cultured at different densities, several density-evoked signals
were demonstrated for the first time. Two of these genes are
deleted in liver cancer-1 (DLC-1), which has never been
studied in primary cells or erythroid cells, and intercellular
adhesion molecule-4 (ICAM-4), which is an erythroid celladhesion protein. Furthermore, we found that ICAM-4 and the
Rho-GTPase-activating protein DLC-1 are binding counterparts
in erythroid cells. Addition of recombinant ICAM-4 protein to
culture media of low-density cells reproduced the results
observed at higher densities, such as enhanced viability and
enucleation.
In this study, we demonstrate that ICAM-4 is related to
the erythropoietic niche between erythroid cells via both
direct contact and through its secreted form. This study
provides new mechanisms by which autonomous control of
erythropoiesis in vivo occurs and could improve in vitro RBC
production for clinical use.
Materials and methods
Isolation of CD34+ cells and culture for
erythroid differentiation
Cord blood (CB) was collected from healthy pregnant women
after obtaining their written informed consent. CD34+ cells
were isolated from the CB using the EasySep CD34 isolation
kit (StemCell Technologies, Vancouver, Canada). The cul-
ture methods are described in a previous report (Baek et al.,
2009, 2010). Several cytokines were added to stroma- and
serum-free media in a stage-specific manner to induce
CD34+ cells to differentiate to a purely erythroid lineage in
the absence of feeder cells and serum/plasma. Live cells
were counted by trypan blue staining.
Cell lines and culture conditions
The human erythroleukemic cell line K562was purchased from
a Korean cell line bank. This line was grown in RPMI 1640
medium (Gibco, Invitrogen, Carlsbad, CA) supplemented with
100 IU/ml penicillin, 100 mg/ml streptomycin, and 10% fetal
bovine serum (FBS; Gibco) in a 5% CO2 incubator at 37 °C.
Cell-density-dependent growth analysis
The cells were found to expand too rapidly to maintain a
constant density. Therefore, cells were maintained at a low
cell density from the beginning of culture until day 17. On day
17 of culture, polychromatic and orthochromatic erythroblasts
were seeded to reach 50% and 100% confluences in order to
mimic the packed cellular environment of bone marrow
(Fig. 1A). Fifty percent and 100% confluences were designated
as optimal (2.5×106 cells/1 ml/2 cm2) or supraoptimal
(5.0×106 cells/2 ml/2 cm2), respectively (Figs. 1B–D). The
cells were kept at the same cell density in the media to
maintain the same level of nutrients and waste. Cultures were
observed under phase contrast microscopy to confirm their
confluence, which was determined by cells flocking to the
center of the plate. Unless otherwise stated, media were
replenished every other day and cell morphology was verified
using Wright–Giemsa staining (Sigma Aldrich, St Louis, MO).
Live cell imaging for cell interactions
Cultured primary erythroid cells were stained with a DiO
cell-labeling solution and observed using live-cell imaging
Figure 1 Erythroid cell cultures at different cell densities. Schematic representation of erythroid cell culture (A–C). Human
erythroid cells derived from cord blood hematopoietic stem cells were cultured. To mimic erythroblastic niches in the bone marrow,
in which erythroid cells are packed without direct contact with macrophages (A), late mature erythroblasts composed of
polychromatic and orthochromatic erythroblasts were seeded at (B) conventional optimal confluence (50%; 2.5×106 cells/1 ml/2 cm2)
and (C) compact supraoptimal confluences (100%; 5.0×106 cells/2 ml/2 cm2) on day 17 of culture. (D) The cells were observed by
phase-contrast microscopy.
444 H.S. Choi et al.microscopy (Deltavision, Applied Precision, Issaquah, WA)
according to the manufacture's protocol.Cell enucleation profiling and viability assay
Cell morphology and enucleation rate experiments were
described in a previous study (Baek et al., 2008, 2009, 2010).
Cell viability was determined using trypan blue staining. For
flow cytometry analysis, cells were stained with AnnexinV-PE
and propidium iodide (BD PharMingen, Franklin Lakes, NJ) for
15 min at room temperature.Analysis of cell surface marker expression by
flow cytometry
Cells were labeled with anti-human antibodies glycophorin A
(GPA)-FITC (BD PharMingen) and CD71-FITC (eBioscience,
San Diego, CA) on days 13 and 17. Immunoglobulin G1
(IgG1)-FITC and IgG1-PE (Beckman Coulter, Miami, FL) were
used as isotype controls. FITC-conjugated anti-Hbf (fetal Hb)
and PerCP-conjugated anti-Hbβ (adult Hb) (BD PharMingen)
were used to measure the intracellular expression ofhemoglobin (Hb). Stained cells were analyzed using flow
cytometry.mRNA expression microarray
To select adhesion-related candidate genes expressed just
before the enucleation phase, we compared the mRNA
expression profiles of proerythroblasts and orthochromatic
erythroblasts at several stages of maturation from three
individual cord blood samples. RNA expression at each
maturation stage was analyzed in triplicate using a NimbleGen
human whole genome mRNA expression microarray (Roche,
Indianapolis, IN). Adhesion-related signals were sought from
among those genes that were upregulated during erythropoie-
sis, especially at the orthochromatic erythroblasts phase.Quantitative RT-PCR
Total RNAwas isolated using Trizol (Invitrogen) according to the
manufacturer's instructions. Total RNA was reverse-transcribed
using SuperScript III Reverse Transcriptase (Invitrogen). mRNA
levels were then measured in triplicate by qRT-PCR using SYBR
445Erythropoietic niche for RBC production in vitroPremix ExTaq (Takara-Bio, Shiga, Japan). The primer sequences
were as follows (forward/reverse):VLA-4, 5′-AGGATGGTGTAAGCGATGGC-3′/5′-TGCTGAAGA
ATTGGCTGAAGTGGTGG-3′;
DLC-1, 5′-AGTGCGTGCAACAAGCGGGT-3′/5′-TCCGGGTAGC
TCTCGCGGTT-3′;
ICAM-4, 5′-CCGGACTAAGCGGGCGCAAA-3′/5′-AGCCACGAA
CTCCGGGCTCA-3′.
Other primer sequences were as described previously
(Baek et al., 2010).
Detection of a secreted form of ICAM-4
Cells were cultured at a density of 1×105 cells/well in 24-well
plates for 48 h. Supernatants were then collected for
measurement of ICAM-4 by enzyme-linked immunosorbent
assay (ELISA). Ninety-six-well plates were coated at 4 °C with
the indicated amounts of anti-ICAM-4 antibody (1:100; Santa
Cruz Biotechnology, Santa Cruz, CA) and 10% FBS in PBS. After
incubation, the plates were washed three times with 0.05%
Tween-20 in PBS. The plates were blocked with 1% BSA in PBS
for 2 h at room temperature. The supernatants were then
added to the plates and incubated for 2 h. The plates were
washed prior to the addition of an HRP-conjugated anti-goat
secondary antibody (1:100; Jackson Immunoresearch Labora-
tories, Avondale, PA). After 1 h of incubation at 37 °C,
sICAM-4 was detected with TMB (tetramethyl benzidine), and
substrate reagent (Biolegend, San Diego, CA) was added for
30 min. Absorbance was measured at 490 nm using a
microplate reader. The absorbance values of the isotype-
matched control antibodies were measured as a blank and
subtracted from the experimental values.
Immunoblotting and immunoprecipitation
To assess the binding of ICAM-4 and DLC-1, cells were
harvested in PBS (phosphate buffered saline) and then lysed
as described previously (Baek et al., 2010). For immunopre-
cipitation, equal amounts of protein were incubated with
anti-ICAM-4 antibody for 2 h at 4 °C. Protein A/G agarose
beads (Santa Cruz) were added to each tube and incubated
overnight at 4 °C. The protein and protein A/G bead complexes
were collected and washed three times with lysis buffer.
Immunoblotting was performed by modification of the tech-
nique described previously (Baek et al., 2010). Immunoblotting
analyses were performed with anti-DLC-1 (Santa Cruz),
anti-ICAM-4 (Abcam, Cambridge, UK), anti-β-actin (Cell
Signaling, Beverly, MA), and anti-GAPDH (Abfrontier, Seoul,
Korea) antibodies.
Analysis of soluble ICAM-4 functions in
terminal erythropoiesis
To show that secreted ICAM-4 is a factor in modulating the
maturation, enucleation, and cell survival regulation of
erythroid cells by adjacent erythroid cells, purified recom-
binant ICAM-4 protein (OriGene Technologies, Baltimore,
MD) was added to the culture media at concentrations of 0,2, 5, and 10 μg/ml. The purified protein was added once the
cells had matured to the orthochromatic erythroblast stage
at day 17 of culture. After further culturing for 24 h, cell
viability, maturation status, enucleation rate, and the level
of dysplasia were evaluated on Wright–Giemsa-stained
slides by counting more than 400 cells per condition.
Biochemical analysis
At day 19, culture media were collected, and glucose
concentrations were determined using an automatic chemical
analyzer (Hitachi, Tokyo, Japan). The pH and potassium ion
(K+) concentrations were analyzed using RapidSystems blood
gas analyzers (Siemens, Medfield, MA). Lactate levels were
measured using an enzymaticmethodwith a Cobas Integra 800
(Roche Diagnostics, Basel, Switzerland).
Statistical analysis
Paired t-tests were used to compare the control and
experimental groups. p-values of less than 0.05 were consid-
ered significant.
Results
Cell-to-cell interactions between erythroid cells allow
enhanced viability and enucleation
The purity of erythroid cells derived from CD34+ cells was
determined using erythroid cell-specific markers. CD71, GPA,
HbF, and Hbβ appeared by day 13, and the cultured cells
consisted almost solely of poly- and orthochromatic cells with
a purity of up to 99% at day 17 (Fig. 2A). Contaminating
macrophages were not visible in pictures taken by phase
contrast microscopy (Fig. 2B) and Wright–Giemsa-stained
slides (Fig. 2C). At higher density, erythroid cell interactions
were observed in 17% of the total cells, as measured by
recorded movie images and shown in Fig. 1D (Fig. 2B).
Enucleation rate and cell integrity, which was defined as
whether a cell showed any vacuoles or a destroyed membrane
contour, were observed by cell staining (Fig. 2C). When
erythroid cells exited the polychromatic stage, cell prolifer-
ation declined and the rate of cell death markedly increased.
In contrast, cells cultured at 100% (supraoptimal density) and
150% confluences showed better morphology, as indicated by
intact cytoplasmic membranes and fewer vacuoles, and
showed substantially increased viability and cell number.
However, cells at 150% confluence did not show enhanced
contact over that seen at 100% confluence, likely because
the excess cells could not adhere to the bottom monolayer
and were instead floating in the media. Therefore, we
compared conventional optimal density (50% confluence)
and supraoptimal density (100% confluence). Compared to
the optimal condition, the supraoptimal condition demon-
strated significantly increased viability (42.9%; Fig. 2D) and
enucleation (38.6%; Fig. 2E). As a result, the supraoptimal
100% confluent cultures showed significantly increased RBC
production, as calculated by the fold-expansion multiplied
by the enucleation rate at the corresponding cell densities
(Fig. 2F).
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terminal-phase erythroid precursors are sensitive to apoptotic
triggering, which is frequently exacerbated in culture
(Tsiftsoglou et al., 2009). Therefore, in order to elucidate
the effects of supraoptimal culture conditions on apoptotic
cell death, we subjected terminal-maturation-stage erythroid
cells to flow cytometry analysis using anti-annexin V and
anti-caspase-3 antibodies, which are markers of apoptosis.
Caspase 3 and annexin V were significantly reduced under the
supraoptimal condition (Fig. 2G) compared to the optimal
condition. This concomitant increase in cell viability, enucle-
ation, and RBC production and decline in apoptotic cell death
suggest that our supraoptimal culture conditions result in
efficient erythroid maturation and, in turn, produce more
RBCs.
To confirm that the connections shown in Fig. 2B were
not due to intercellular bridges at the telophase stage of
cytokinesis, we continuously observed two daughter cells that
had just completed cell division with real-time fluorescence
imaging instead of confocal microscopy. We found that
completely separated cells restored contact via pseudopod-
like connections (Fig. 2H). The connections were maintained
for up to 30 min. This is the first report in the literature to
show autonomous binding of erythroid cells (Figs. 2B and H).
The culture media were also analyzed for soluble contents
by biochemical analysis, and it was found that the culture
media did not differ significantly between the low- and
high-density cultures over the entire culture period (Fig. 2I).
Physical interaction affects terminal erythroid
maturation at the molecular level
Based on the positive effects of supraoptimal density on RBC
yield in vitro, we explored the possible roles of supraoptimal
cultural conditions on erythroid maturation surface markers
and signals. Themedia and culture plates were changed every
two days and just before the density experiments to eliminate
adherent macrophages. When poly- or orthochromatic
erythroid cells at different densities were exposed to erythroid
cell markers, the expression levels of membrane-bound CD71
and GPA did not differ between conditions (mean expression
value: CD71N53.7%, GPAN87.3%). This was likely because CD71
is expressed until the reticulocytes stage and maturation to
mature red blood cells could not be completed within the short
culture duration (Fig. 3A). However, mRNA levels of GATA-1
and Hbβ, the expression of which increased along with
erythropoiesis, were significantly higher at higher densities
(Fig. 3B). Altogether, these results indicate that culture density
affects maturation signaling.
Expression of ICAM-4 and VLA-4 induced by
homogenous erythroid cell contacts
Of the total 45,034 genes measured by the microarray, 2133
genes were upregulated during erythroid cell maturation.
Among the cell adhesion genes, 96 genes were expressed in
the orthochromatic erythroblasts at levels more than 1.5-fold
those found in proerythroblasts. In particular, DLC-1 gene
expression was highest, with a 4.0-fold relative change in
expression.We selected the erythroid-specific adhesionmarker
ICAM-4 and VLA-4 for further study. We first determined themRNA expression level of ICAM-4 and VLA-4 by RT-PCR (Fig. 4A).
Matured erythroid cells grown at different densities were
compared using qRT-PCR, and the mRNA levels of ICAM-4 and
VLA-4 were found to be markedly increased at higher densities
(Fig. 4B). The induction of ICAM-4 mRNA expression was
paralleled by an increase in ICAM-4 protein in the erythroid
cells that maturated at a higher density (Fig. 4C).
DLC-1 is expressed in human erythroid cells and
is associated with physical interactions among
erythroid cells
From the mRNA microarray data, it was determined that the
DLC-1 mRNA expression levels of basophilic erythroblasts,
orthochromatic erythroblasts, and reticulocytes increased
1.60-, 4.0-, and 3.64-fold compared to proerythroblasts. On
the basis of the analysis of microarray data, we confirmed
the expression of DLC-1 in erythroid cells at culture days 8
and 17 by qRT-PCR (data not shown). In addition, the
dose-dependent expression of DLC-1 in human erythroid cells
was verified in the human erythroleukemic cell line K562
(Fig. 5A).
To confirm the change in DLC-1 at different cell
densities, we performed immunoblotting and qRT-PCR in
mature erythroid cells. Compared to the optimal group, the
supraoptimal group showed increased levels of DLC-1 mRNA
and protein (Figs. 5B and C). These results suggest that
DLC-1 is associated with physical interactions among erythroid
cells.
DLC-1 is a novel binding counterpart of ICAM-4
Since both DLC-1 and ICAM-4 were expressed at higher levels
with increasing physical contact between the human erythroid
cells, we investigated whether DLC-1 might interact with
ICAM-4 in the K562 cell line. As shown Fig. 6A, the immunopre-
cipitation of endogenous ICAM-4 with a specific antibody
precipitated endogenous DLC-1 as revealed by Western
blotting. This result convincingly demonstrates that the
association between DLC-1 and ICAM-4 is not only specific, but
also physiologically relevant. We also determined the localiza-
tion of DLC-1 and ICAM-4 by fluorescence (Fig. 6B).
These results suggest that DLC-1 and ICAM-4, the functions
of which in erythroblast–erythroblast adhesion were not
evaluated, affected terminal erythropoiesis in terms of
enhancing viability and enucleation.
ICAM-4 enhances terminal erythropoiesis by
decreasing abnormal cytokinesis in vitro
In order to evaluate whether ICAM-4 has a soluble form
(sICAM-4) in humans, the cell supernatants were collected and
analyzed for the presence of sICAM-4 by ELISA. Approximately
40% and 10% greater signals were detected in K562 andmature
erythroid cells, respectively, compared to the media alone
(Fig. 7A).
To confirm that ICAM-4 could reproduce the results of
increased viability and enucleation with decreased dysplasia
seen under the supraoptimal density conditions, soluble
ICAM-4 protein was added to the terminally matured cells at
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cell-to-cell contact, the erythroid cells were maintained at a
low-density optimal condition. More than 400 cells for each
condition were counted after cell staining (Fig. 7B). The
results indicate that soluble ICAM-4 increases the number of
viable cells in a dose-dependent manner (Fig. 7C). On the
other hand, nuclear dysplasia, such as bi-/multi-nucleation
and nuclear fragmentation, was markedly diminished in a
dose-dependent manner with increased concentrations of
ICAM-4 (Fig. 7D). To compare maturation enhancement, the
number of cells with different maturation statuses were
counted. In addition, the enucleation rate increased more in
ICAM-4-treated cells than in untreated cells (11% and 22%,
respectively). More mature cells were counted at the higher
concentration of ICAM-4. This, taken together with the high
enucleation rate, suggests that ICAM-4 has an important roleFigure 2 Effects of cell culture density on the terminal matu
cell-specific markers were measured by flow cytometry. (B) The e
different densities. Erythroid cells could contact each other at a su
charges. (C) Erythroid cells stained with Wright–Giemsa. Arrows in
erythroid cells stained with trypan blue was significantly increased at
erythroid cells wasmeasured in comparison to the optimal condition (n
cells at each culture density were quantified using flow cytometry anal
is presented (n=3). (H) Erythroid cells were cultured for 13 days and w
The upper arrow indicates cell division and the lower arrows indicate ce
day 19, and lactate, glucose, the potassium ion (K+) concentrations, a
error of the mean (SEM). pb0.05, significantly different from the optimin influencing enucleation and RBC production in terminal
erythropoiesis (Figs. 7E and F).Discussion
Cell-to-cell communication through the attachment of
erythroid cells to macrophages is critical for erythroid cell
differentiation and maturation (Chasis and Mohandas, 2008).
However, during the maturation period, erythroid cells at the
outer edge of an erythroblastic island progressively lose their
adhesion ligands to the adjacent macrophage (Mohandas and
Chasis, 2010). Moreover, some erythroid cells exist outside of
these islands and form clusters by themselves (Chasis, 2006).
There have been some studies on the interactions between
immature erythroid cells (via Emp) (Soni et al., 2006) andration of erythroid cells. (A) At day 17 of culture, erythroid
rythroid cells were then distributed to new culture plates at
praoptimal density despite repulsion induced by their negative
dicate reticulocytes. Magnification: 200×. (D) The viability of
the supraoptimal density. (E) The enucleation rate of maturated
=6) along with (F) the number of erythrocytes (n=8). (G) Apoptotic
ysis with annexin V staining. The ratio of cells undergoing apoptosis
ere stained with fluorescent DiO for 5 min at room temperature.
lls interacting with each other. (I) Culturemedia were collected at
nd pH were determined. Results are expressed as mean±standard
al density group.
Figure 2 (continued).
448 H.S. Choi et al.between immature and mature erythroid cells (via ICAM-
4-VLA-4 and Fas-FasL proteins) (Chasis, 2006; Manwani and
Bieker, 2008; Soni et al., 2006; Hermand et al., 2000; Spring et
al., 2001). However, the ligands related to communication
within erythroid cells in the late stages of maturation
(polychromatic and orthochromatic erythroblasts) have not
been studied, nor has any mechanism for autonomousCD71 GPA
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Figure 4 Expression of ICAM-4 in human erythroid cells. Total RNA was isolated from cultured mature erythroid cells over 17 days.
(A) ICAM-4 and VLA-4 mRNA levels were measured by RT-PCR (M: marker, 1: VLA-4, 2: ICAM-4, 3: β-actin). (B) RNA was prepared from
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loaded on a 12% gel. The same membrane was stripped and re-probed with anti-GAPDH antibody. Expression of GAPDH was used to
normalize the intensity of the ICAM-4 band on the immunoblot. Data represent the four independent experiments.
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nts of protein. (B) From the erythroid cells cultured at different
ed using qRT-PCR. Relative expression levels were normalized to
from the different culture densities were prepared for Western
ripped and reprobed with anti-β-actin antibody. Expression of
on the immunoblot. Data represent the three independent
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Figure 6 Endogenous interactions between DLC-1 and ICAM-4 in human erythroid cells. (A) Cell lysates were prepared from K562
cells. Immunoprecipitation was performed with anti-ICAM-4 (29 kDa) and anti-IgG (negative control) antibodies and then subjected to
immunoblotting to detect interactions between ICAM-4 and anti-DLC-1 (123 kDa). Data represent three independent experiments.
(B) Immunofluorescence confocal microscopy was used to explore interactions between DLC-1 (Red) and ICAM-4 (Green) from
primary erythroid cells at day 17 of culture. Complexes between endogenous DLC-1 and ICAM-4 were found in the cytosol of cells.
Insets show enlarged images (scale bar, 25 μm). The pictures are representative of the three independent experiments.
450 H.S. Choi et al.bridges between erythroid cells, a finding not previously
demonstrated in the literature (Figs. 2B and H). We propose
that cell-to-cell contact mimics in vivo cell maturation
conditions, possibly through various stimuli. Therefore, the
erythroid cells cultured under high density conditions were
found to have diminished numbers of apoptotic cells and
higher numbers of viable cells. This indicates that the cells
matured under lower stress and with less damage, which can
accumulate in normal in vitro culture conditions.
In an attempt to identify the responsible key molecules
and proteins, we selected several adhesion-related candidate
genes from the microarray analysis results from during the
enucleation stages. We discovered several enucleation-
related signals, such as DLC-1, ICAM-4, and VLA-4. Among
these, DLC-1 and ICAM-4 were significantly increased in the
high-density cultures, perhaps due to the increased cell-to-
cell contact. Even though ICAM-4 is known to be an adhesive
ligand in erythroid cells, the expression of DLC-1 in erythroid
cells was unexpected. Therefore, the consistent expression of
DLC-1 in an erythroid lineage was verified in K562 cells.
DLC-1 was recently studied in various tumor cells, including
breast cancer and colon cancer (Healy et al., 2008; Kim et al.,
2008a, 2008b; Yuan et al., 2003). This RhoA-specific GTPase-
activating protein regulates a variety of cellular processes,
including actin cytoskeleton organization, cell adhesion to the
extracellular matrix, the cell cycle (Gabet et al., 2011; Kim et
al., 2008a, 2008b, 2009), and enhanced protrusion (Kim et al.,
2008a, 2008b). Interestingly, all of these processes are
required to complete the terminal phase of erythropoiesis
and enucleation. Also, the GTPase and GTPase activatingprotein is known to be very essential for the enucleation
process (Ji et al., 2008).
Our finding that DLC-1 expression increased at higher
densities concurrent with elevated enucleation rates suggest
that DLC-1 is a novel contact-related signal among erythroid
cells and might play a role in the enucleation process.
As both DLC-1 and ICAM-4 expression increased at higher
densities, we postulate that ICAM-4 might interact with
DLC-1 in erythroid cells in a manner similar to the way in
which ICAM-1 induces Rho GTPase activation in endothelial
cells via adhesion-related proteins (Etienne et al., 1998).
DLC-1 is also known to co-localize with the adhesion proteins
vinculin and tensin in focal adhesions (Kim et al., 2007; Xue et
al., 2008; Chan et al., 2009). Focal adhesions form structural
links between the actin cytoskeleton and the extracellular
matrix and serve as signal transduction centers for cell growth
regulation (Burridge and Chrzanowska-Wodnicka, 1996; Xue
et al., 2008). This could indicate that cell-to-cell interaction
induces DLC-1 activation along with ICAM-4, which also plays
an important role during terminal erythropoiesis and enucle-
ation. Further study is needed to identify the roles of DLC-1 in
this complicated network.
ICAM-4 is a uniquemember of the ICAM family expressed on
erythroid cells. It binds to VLA-4 during the differentiation of
erythroid precursors and the organization of erythroblastic
islands (Eshghi et al., 2007; Spring et al., 2001). Even though
VLA-4 is present on erythroid cells, the precise relationship and
function of VLA-4 on erythroblasts has not been elucidated.
Contamination by macrophages, which also express VLA-4,
was not observed with phase contrast microscopy or on
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Figure 7 Effects of soluble ICAM-4 on terminal erythropoiesis. (A) The erythroid cells at culture day 17 and K562 cells were
prepared to assess the existence of a soluble form of ICAM-4. Culture supernatants of the erythroid cells and K562 cells were
collected, and the levels of ICAM-4 were measured by ELISA (n=3, measured in triplicate). (B) Erythroid cells stained with Wright–
Giemsa. Blue arrows indicate dysplastic erythroid cells with multi-nucleation and nuclear protrusions. Red stars indicate enucleated
RBCs. Magnification: 200×. With an increase in ICAM-4 concentration, the viability of erythroid cells significantly increased as shown
by trypan blue staining (C), nuclear dysplasia decreased (D), maturation status progressed (E), and subsequently, the number of
enucleated RBCs increased (F). Data represent three independent experiments, which were performed in duplicate. After pictures
were taken, at least 400 cells per condition were counted in a blinded manner.
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452 H.S. Choi et al.Wright–Giemsa-stained slides. When the cultured cells were
stained with anti-CD11b antibody, which recognizes myeloid
cells and monocytes as well as macrophages, and analyzed by
flow cytometry, similar percentages of CD11b-positive cells
were detected for the optimal and supraoptimal samples
(mean 4.6% vs. 4.2%, respectively, n=2; controls were
macrophages in ascites from patients with liver cirrhosis). As
the purity of erythroid cells was not 100%, there could have
been some effects from other cell lineages, including
macrophages. However, when erythroid cells were mixed
with macrophages, we found that most erythroid cells bound
to the macrophages, even at the lower density (data not
shown). Therefore, the macrophage–erythroid cell binding
effect did not differ significantly between density conditions.
More importantly, our results show that erythroid cells have
connections, as demonstrated by the presence of bridges
between erythroid cells and by the expression of adhesion
markers (Figs. 2 and 6). Also, the effects of sICAM-4 could not
be devaluated by the presence of a few macrophages and
myeloid cells (Fig. 7).
For the first time, we showed that a secreted form of
human ICAM-4 (sICAM-4) is made from human erythro-
blasts. Similarly, erythroblasts derived from murine Friend
virus anemia (FVA) cells are known to secrete ICAM-4
(Ihanus et al., 2007; Lee et al., 2003). As the erythroblasts
mature, they reside in areas peripheral to macrophages
within the erythroblastic island (Bain et al., 1996), and
the direct effects ofmacrophages decrease and the effects of
adjacent erythroid cells increase. We therefore speculated
that the addition of the sICAM-4 could mimic co-stimulation
among erythroblasts.
The addition of recombinant ICAM-4 enhanced cell
differentiation to RBCs by decreasing abnormal cytokinesis
in vitro. Such abnormal cytokinesis is known as nuclear
dysplasia, and occurs when the nucleus does not properly
divide to form daughter cells. These dysplastic cells show
multi-nucleation states, fragmented nuclei, or irregular
nuclear contours. Erythroid dysplasia leads to inefficient
enucleation and cell death in vivo and in vitro. The role of
DLC-1 in cytokinesis and co-binding with ICAM-4 suggests
that the effects induced by ICAM-4 are related to DLC-1. This
relationship should be further evaluated in culture systems
and in pathologic diseases in vivo.
The elucidation of the role of sICAM-4 is also important
for practical purposes. The progressive loss of viable cells
during successive stages of cell culture is well known,
especially in terminally matured erythroblasts, resulting in
inefficient generation of RBCs. Rigorous attempts have been
made to create a platform for efficient erythrocyte production,
but these attempts have met with failure. In our culture
system, with its absence of supporting stromal cells and serum/
plasma, a supraoptimal density led to significantly enhanced
cell survival, enucleation, and finally, to a higher amount of
generated RBCs, indicating that erythroblast-erythroblast
contact may mimic in vivo conditions (Chasis, 2006). Even
though these erythroblast contacts do not equal the most
powerful effects of macrophages on erythropoiesis, the
availability of sICAM-4 for in vitro terminal erythropoiesis is
valuable. This clearly suggests that our culture system, with its
addition of sICAM-4, could be used for mass RBC production
using a bioreactor by reducing culture area and enhancing
culture efficiency.Culturing precursor cells of hematopoietic origin at a high
density induces a “crowding” effect, which results in a general
decline in metabolic activity (Sand et al., 1977). Additional
evidence demonstrates that inhibitory cytokines can accumu-
late in cultures through lactate production (Sand et al., 1977).
Therefore, we analyzed conditioned media to investigate the
effects of culture density on cell metabolism, and did not
observe any variations in metabolic activity or cellular
homeostasis.
For the relatively low enucleation rate in this report, the
likely reason is that the culture conditions were deprived of
serum/plasma and stromal cells. Other reports showing
higher enucleation rates of more than 50% were performed
in the setting of the addition of serum/plasma or feeder
factors.
In summary, our findings indicate the importance of
physical contact between erythroid cells during terminal
maturation. At a higher density, which increases the chances
of cell-to-cell contact, the viability, expansion rate, and
enucleation rate of erythroblasts increased significantly.
The adhesion-related molecule ICAM-4 and its counterpart
VLA-4 were highly expressed under these conditions. DLC-1
was also found to be co-expressed with ICAM-4 in erythro-
blasts. The presence of the soluble form of ICAM-4 was first
confirmed in human erythroblasts. Next, the addition of
soluble ICAM-4 during the terminal maturation phase of
erythroblasts decreased nuclear dysplasia and elevated cell
viability and RBC production. Contact with adjacent
erythroblasts might play a crucial role in the formation of
terminally matured erythroblasts, which are not in direct
contact with macrophages, through ICAM-4- and DLC-1-
mediated signaling.
Our findings could be applied to a bioreactor system to
effectively and efficiently produce RBCs. Better productivity
at high density could enable a reduction in culture area and
an increase in cell number at limited culture volumes. The
effects of the soluble form of ICAM-4 are readily applicable
by simply adding it to any kind of bioreactor, including the
agitator type, thus mimicking the highly compacted cellular
environment of bone marrow. Since there are currently no
known cytokines in terminal erythropoiesis, sICAM-4 would
be one of the few reagents available to increase the viability
and productivity of RBCs.
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